<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03504800</url>
  </required_header>
  <id_info>
    <org_study_id>IRB#000018036</org_study_id>
    <nct_id>NCT03504800</nct_id>
  </id_info>
  <brief_title>OCT in Diagnosis of Irregular Corneas</brief_title>
  <official_title>Optical Coherence Tomography-Aided Differential Diagnosis and Treatment of Irregular Corneas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oregon Health and Science University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
  </oversight_info>
  <brief_summary>
    <textblock>
      This main goal of this study is to improve the detection, classification, monitoring, and
      treatment of irregular corneas due to keratoconus, warpage, dry eye, scar, stromal
      dystrophies, and other corneal conditions.

      The primary goal will be achieved by using optical coherence tomography (OCT) to:

        1. Develop an OCT-based system to classify and evaluate corneal-shape irregularities.

        2. Develop OCT metrics for more sensitive detection of keratoconus progression.

        3. Develop OCT-and-topography guided phototherapeutic keratectomy (PTK) for irregular
           corneas.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 2018</start_date>
  <completion_date type="Anticipated">April 2023</completion_date>
  <primary_completion_date type="Anticipated">April 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>OCT-based Classification of Corneal Irregularities</measure>
    <time_frame>1 day</time_frame>
    <description>Clinical classification of keratoconus, epithelial deformation, stromal addition/subtraction, stromal distortion, and healthy controls by OCT.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Detection of Keratoconus Progression by OCT</measure>
    <time_frame>4 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>OCT-and-Topography Guided PTK</measure>
    <time_frame>1 year</time_frame>
    <description>OCT-and-Topography guided PTK treatment for participants with stromal addition/subtraction or stromal distortion.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">445</enrollment>
  <condition>Keratoconus</condition>
  <condition>Corneal Opacity</condition>
  <condition>Corneal Dystrophy</condition>
  <arm_group>
    <arm_group_label>Group A: Classification of Corneal Irregularities</arm_group_label>
    <description>This group will consist of participants &gt;14 years old with various types of corneal irregularities. Their data will be compared against participants with healthy corneas. Data for this group will be gathered only once.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B: Detection of Keratoconus Progression</arm_group_label>
    <description>Participants from Group A who are diagnosed with keratoconus will be selected for this longitudinal study to monitor keratoconus progression. They will be followed up to 4 years.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C: OCT-and-Topography Guided PTK</arm_group_label>
    <description>Participants from Group A will be selected for this group if they have vision primarily limited by scars, dystrophy, or high astigmatism that could be treated by PTK. They will be followed up to 1 year.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Optical Coherence Tomography</intervention_name>
    <description>This device will be used to tightly classify corneal irregularities and determine eligibility of candidates from Group A into Groups B &amp; C.</description>
    <arm_group_label>Group A: Classification of Corneal Irregularities</arm_group_label>
    <arm_group_label>Group B: Detection of Keratoconus Progression</arm_group_label>
    <arm_group_label>Group C: OCT-and-Topography Guided PTK</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        A total of 445 participants ages 14 or older will be recruited for the 3 clinical studies.
        All 3 studies will be performed at the Casey Eye Institute at Oregon Health &amp; Science
        University.

        Group A:

          -  Keratoconus: 150 participants

          -  Epithelial deformation: 105 participants; This category includes contact lens-related
             corneal warpage, dry eye, and EBMD.

          -  Primary stromal changes: 100 participants; This category includes corneal scars,
             Salzmann's degeneration, stromal dystrophies, complicated LASIK/PRK cases with visual
             complaints, RK cases, and corneal transplants.

          -  Healthy Controls: 90 participants
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        GROUP A:

          -  Keratoconus:

               1. CDVA ≥ 20/25 in the better eye; and both of the following in the worse eye

               2. Topography characteristic of keratoconus or pellucid marginal degeneration

          -  Contact lens-related corneal warpage:

               1. Contact lens use; and

               2. Topography irregularities

          -  Dry eye:

               1. Symptoms of dry eye documented by Ocular Surface Disease Index (OSDI)
                  questionnaire score ≥ 30; and

               2. Topography irregularities

               3. Presence of punctate epithelial erosion on exam with surface staining

               4. Aqueous deficiency or evaporative dry eye

          -  Epithelial basement membrane dystrophy (EBMD):

               1. Negative corneal fluorescein staining; and

               2. Corneal opacities; and

               3. Topography irregularities

          -  Stromal addition or subtraction:

               1. Scars; or

               2. Salzmann's degeneration; or

               3. Stromal dystrophies; or

               4. Complication (visual complaints) after LASIK or photorefractive keratectomy (PRK)

          -  Stromal distortion:

               1. Radial keratectomy (RK); or

               2. Corneal transplants.

          -  Normal controls:

               1. Healthy eyes with no previous eye procedures/surgeries.

        GROUP B:

        Participants will be selected from the keratoconus population in Group A based on
        topography findings.

        GROUP C:

        Participants will be selected from the stromal addition/subtraction and stromal distortion
        populations of Group A if they have vision primarily limited by scars, dystrophy, or high
        astigmatism that could benefit from PTK.

        Exclusion Criteria (all groups):

          -  Inability to give informed consent.

          -  Inability to maintain fixation for OCT imaging.

          -  Inability to commit to required study visits.

          -  Eyes with concurrent cataract, retinal disease, glaucoma, or other eye conditions that
             may limit the visual outcome after surgery.

          -  Previous corneal surgeries if considered as a keratoconus participant.

          -  Pregnancy or breastfeeding.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maolong Tang, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oregon Health and Science University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Omkar Thaware, B Optom, MSVS</last_name>
    <phone>503-494-7398</phone>
    <email>thaware@ohsu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Denny Romfh, OD</last_name>
    <phone>503-494-4351</phone>
    <email>romfhd@ohsu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Omkar Thaware, B Optom, MSVS</last_name>
      <phone>503-494-7398</phone>
      <email>thaware@ohsu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Denny Romfh, OD</last_name>
      <phone>503-494-4351</phone>
      <email>romfhd@ohsu.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Maolong Tang, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Huang, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Winston Chamberlain, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Clements, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Afshan Nanji, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lorinna Lombardi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ellen Davis, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Seema Gupta, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yan Li, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xinbo Zhang, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 11, 2018</study_first_submitted>
  <study_first_submitted_qc>April 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 20, 2018</study_first_posted>
  <last_update_submitted>April 19, 2018</last_update_submitted>
  <last_update_submitted_qc>April 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oregon Health and Science University</investigator_affiliation>
    <investigator_full_name>David Huang</investigator_full_name>
    <investigator_title>Maolong Tang, PhD, Assistant Professor of Ophthalmology</investigator_title>
  </responsible_party>
  <keyword>OCT</keyword>
  <keyword>Keratoconus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconus</mesh_term>
    <mesh_term>Corneal Opacity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

